Bio-Techne (TECH) Receivables - Net (2010 - 2026)

Bio-Techne's Receivables - Net history runs 17 years deep, the most recent figure standing at $214.6 million for Q1 2026.

• In Q1 2026, Receivables - Net fell 9.52% year-over-year to $214.6 million; the TTM figure through Mar 2026 stood at $214.6 million (down 9.52% YoY), while the FY2025 annual figure was $206.9 million, down 14.3% from the prior year.
• Receivables - Net for Q1 2026 stood at $214.6 million, up from $184.6 million in the prior quarter.
• The five-year high for Receivables - Net was $241.4 million in Q2 2024, with the low at $174.2 million in Q3 2022.
• The 5-year median for Receivables - Net is $207.5 million (2023), against an average of $208.3 million.
• The sharpest annual moves came in 2022 and 2025: Receivables - Net surged 33.82% in 2022, then slipped 17.79% in 2025.
• Bio-Techne's Receivables - Net stood at $184.8 million in 2022, then rose by 12.28% to $207.5 million in 2023, then advanced by 5.06% to $217.9 million in 2024, then slipped by 15.29% to $184.6 million in 2025, then increased by 16.22% to $214.6 million in 2026.
• Business Quant data shows TECH's Receivables - Net at $214.6 million in Q1 2026, $184.6 million in Q4 2025, and $183.9 million in Q3 2025.